Clinical Trials

Phase III Randomized Study Testing Non-inferiority of Short-course Ultra-hypofractionated Radiation (UHRT-5) Versus Standard Fractionation (RT-25) For Stage II-IIIB, Extremity, Resectable Soft Tissue Sarcoma

ClinicalTrials.gov Identifier

ClinicalTrials.gov registration not required

Principal Investigator

Eva Galvan MD

For more information about this study
View Details

About This Study

We propose a clinical trial comparing standard radiation (RT-25) to ultra-hypofractionated radiation (UHRT-5). If negative, this trial would stop participants from being treated, as many are, with an inferior regimen. If positive, this trial would establish a new standard of care